Your challenge: You are competing in emerging markets with little data
If you are challenged with accelerating growth in an emerging market but lack the power of the tools and data the bigger markets have, you still need to make robust decisions with certainty, and minimize your risk.
Are you:
- concerned about how to get the hard facts required to support your decision making?
- justifying budget decisions with little evidence?
- relying on second hand data or ‘gut feel’?
Our solution
94.8 solves present depth and granularity of emerging market data by ensuring the data used is collected at the time of the analytics. We ensure high quality by not using second hand data but collecting our own, verified, meticulously processed and incisive facts and figures.
You’ll know:
- the key drivers in this market for your therapeutic area
- the key driver messages by doctor segment and indication in that market
- the key driver rep and communication channels by doctor segment and indication in that market
- what really influences prescribers to continue or change prescribing behavior
- how to allocate resources across channels, segments, indications, brands and even across regions for maximum return
- the core changes needed to accelerate growth for your brand
- where the best market opportunities lie and how to access them